Skip to main content

Adma Biologics, Inc.

ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001368514

No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.

13F holders, Q3 2022

Institutional positions in Adma Biologics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
130
+17 vs. Q2 2022
Shares held
129.8M
+10.5M (+8.8%) vs. Q2 2022
Total value
$315.4M
+$79.3M (+33.6%) vs. Q2 2022
New holders
28
43 more added
Sold out
11
33 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 130 institutions
Q1 2021: 104 institutionsQ2 2021: 90 institutionsQ3 2021: 72 institutionsQ4 2021: 88 institutionsQ1 2022: 105 institutionsQ2 2022: 113 institutionsQ3 2022: 130 institutionsQ4 2022: 160 institutionsQ1 2023: 163 institutionsQ2 2023: 179 institutionsQ3 2023: 188 institutionsQ4 2023: 184 institutionsQ1 2024: 214 institutionsQ2 2024: 253 institutionsQ3 2024: 306 institutionsQ4 2024: 321 institutionsQ1 2025: 347 institutionsQ2 2025: 369 institutionsQ3 2025: 366 institutionsQ4 2025: 357 institutionsQ1 2026: 358 institutionsQ2 2026: 322 institutions
Value heldQ3 2022: $315.4M
Q1 2021: $85.4MQ2 2021: $68.6MQ3 2021: $47.3MQ4 2021: $137.1MQ1 2022: $189.9MQ2 2022: $236.0MQ3 2022: $315.4MQ4 2022: $592.2MQ1 2023: $547.2MQ2 2023: $610.6MQ3 2023: $612.7MQ4 2023: $764.6MQ1 2024: $1.16BQ2 2024: $2.03BQ3 2024: $4.16BQ4 2024: $3.50BQ1 2025: $4.07BQ2 2025: $3.84BQ3 2025: $3.28BQ4 2025: $4.02BQ1 2026: $1.91BQ2 2026: $1.70B
Institutions holding ADMA and their total value by quarter
QuarterHoldersValue
Q2 2026322$1.70B
Q1 2026358$1.91B
Q4 2025357$4.02B
Q3 2025366$3.28B
Q2 2025369$3.84B
Q1 2025347$4.07B
Q4 2024321$3.50B
Q3 2024306$4.16B
Q2 2024253$2.03B
Q1 2024214$1.16B
Q4 2023184$764.6M
Q3 2023188$612.7M
Q2 2023179$610.6M
Q1 2023163$547.2M
Q4 2022160$592.2M
Q3 2022130$315.4M
Q2 2022113$236.0M
Q1 2022105$189.9M
Q4 202188$137.1M
Q3 202172$47.3M
Q2 202190$68.6M
Q1 2021104$85.4M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Adma Biologics, Inc.; share changes are against Q2 2022.

Institutions holding ADMA in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC638,400$1.55M0.00%−87,100−12.0%Reduced
EAM Global Investors LLC836,323$2.03M0.54%00.0%Unchanged
Schonfeld Strategic Advisors LLC838,466$2.04M0.02%−220,175−20.8%Reduced
Bank of America Corp959,303$2.33M0.00%+320,367+50.1%Added
Tang Capital Management LLC992,840$2.41M0.30%+992,840New
Assenagon Asset Management S.A.1,067,747$2.60M0.01%−21,360−2.0%Reduced
Two Sigma Investments, LP1,325,982$3.22M0.01%+764,545+136.2%Added
Verition Fund Management LLC1,369,552$3.33M0.05%+1,344,560+5,380.0%Added
EAM Investors, LLC1,427,160$3.47M0.75%+179,024+14.3%Added
Northern Trust Corp1,584,256$3.85M0.00%−19,041−1.2%Reduced
Millennium Management LLC1,727,003$4.20M0.01%−4,162,968−70.7%Reduced
Hudson Bay Capital Management LP2,017,265$4.90M0.05%−133,307−6.2%Reduced
Morgan Stanley2,357,621$5.73M0.00%+1,498,858+174.5%Added
Bridgeway Capital Management, LLC2,450,300$5.95M0.16%+2,187,200+831.3%Added
Clearline Capital LP2,496,297$6.07M0.85%−421,963−14.5%Reduced
Fred Alger Management, LLC2,864,218$6.96M0.04%+2,864,218New
Altium Capital Management LP2,883,710$7.01M2.64%−1,116,290−27.9%Reduced
Geode Capital Management, LLC3,286,129$7.99M0.00%+94,001+2.9%Added
Invesco Ltd.3,425,749$8.32M0.00%+3,109,896+984.6%Added
Magnetar Financial LLC4,371,408$10.6M0.15%−2,489,464−36.3%Reduced
Stonepine Capital Management, LLC5,000,000$12.2M5.46%−2,000,000−28.6%Reduced
AWM Investment Company, Inc.5,015,000$12.2M1.85%00.0%Unchanged
Velan Capital Investment Management LP5,269,155$12.8M14.99%−804,443−13.2%Reduced
D. E. Shaw & Co., Inc.5,843,796$14.2M0.02%+1,011,404+20.9%Added
Boothbay Fund Management, LLC8,121,153$19.7M0.67%−2,239,247−21.6%Reduced
Nuveen Asset Management, LLC8,703,733$21.1M0.01%+1,541,544+21.5%Added
Vanguard Group Inc9,290,699$22.6M0.00%+250,455+2.8%Added
State Street Corp9,423,422$22.9M0.00%+6,459,197+217.9%Added
Perceptive Advisors LLC10,933,387$26.6M0.77%−587,715−5.1%Reduced
BlackRock Inc.12,975,594$31.5M0.00%+384,868+3.1%Added
Polar Asset Management Partners Inc.0$00.00%−600,000−100.0%Sold out
Kent Lake Capital LLC0$00.00%−271,119−100.0%Sold out
Alpine Global Management, LLC0$00.00%−250,000−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−55,300−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−36,000−100.0%Sold out
Eagle Asset Management Inc0$00.00%−28,833−100.0%Sold out
Wealthstream Advisors, Inc.0$00.00%−18,000−100.0%Sold out
Viewpoint Capital Management LLC0$00.00%−13,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−9,070−100.0%Sold out
Global Wealth Management Investment Advisory, Inc.0$00.00%−500−100.0%Sold out
Captrust Financial Advisors0$00.00%−40−100.0%Sold out